172 related articles for article (PubMed ID: 22213241)
1. A method for analyzing the business case for provider participation in the National Cancer Institute's Community Clinical Oncology Program and similar federally funded, provider-based research networks.
Reiter KL; Song PH; Minasian L; Good M; Weiner BJ; McAlearney AS
Cancer; 2012 Sep; 118(17):4253-61. PubMed ID: 22213241
[TBL] [Abstract][Full Text] [Related]
2. The business case for provider participation in clinical trials research: an application to the National Cancer Institute's community clinical oncology program.
Song PH; Reiter KL; Weiner BJ; Minasian L; McAlearney AS
Health Care Manage Rev; 2013; 38(4):284-94. PubMed ID: 23044836
[TBL] [Abstract][Full Text] [Related]
3. Why providers participate in clinical trials: considering the National Cancer Institute's Community Clinical Oncology Program.
McAlearney AS; Song PH; Reiter KL
Contemp Clin Trials; 2012 Nov; 33(6):1143-9. PubMed ID: 22925970
[TBL] [Abstract][Full Text] [Related]
4. Challenges and facilitators of community clinical oncology program participation: a qualitative study.
McAlearney AS; Reiter KL; Weiner BJ; Minasian L; Song PH
J Healthc Manag; 2013; 58(1):29-44; discussion 45-6. PubMed ID: 23424817
[TBL] [Abstract][Full Text] [Related]
5. Implementing community-based provider participation in research: an empirical study.
Teal R; Bergmire DM; Johnston M; Weiner BJ
Implement Sci; 2012 May; 7():41. PubMed ID: 22568935
[TBL] [Abstract][Full Text] [Related]
6. Organizational and physician factors associated with patient enrollment in cancer clinical trials.
Jacobs SR; Weiner BJ; Reeve BB; Weinberger M; Minasian LM; Good MJ
Clin Trials; 2014 Oct; 11(5):565-75. PubMed ID: 24902923
[TBL] [Abstract][Full Text] [Related]
7. Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program.
Carpenter WR; Fortune-Greeley AK; Zullig LL; Lee SY; Weiner BJ
Contemp Clin Trials; 2012 Jan; 33(1):46-54. PubMed ID: 21986391
[TBL] [Abstract][Full Text] [Related]
8. Provider-based research networks may improve early access to innovative colon cancer treatment for African Americans treated in the community.
Penn DC; Chang Y; Meyer AM; DeFilippo Mack C; Sanoff HK; Stitzenberg KB; Carpenter WR
Cancer; 2015 Jan; 121(1):93-101. PubMed ID: 25209056
[TBL] [Abstract][Full Text] [Related]
9. Organizational designs for achieving high treatment trial enrollment: a fuzzy-set analysis of the community clinical oncology program.
Weiner BJ; Jacobs SR; Minasian LM; Good MJ
J Oncol Pract; 2012 Sep; 8(5):287-91. PubMed ID: 23277765
[TBL] [Abstract][Full Text] [Related]
10. Achieving high cancer control trial enrollment in the community setting: an analysis of the Community Clinical Oncology Program.
Jacobs SR; Weiner BJ; Minasian LM; Good MJ
Contemp Clin Trials; 2013 Mar; 34(2):320-5. PubMed ID: 23295315
[TBL] [Abstract][Full Text] [Related]
11. Provider-based research networks and diffusion of surgical technologies among patients with early-stage kidney cancer.
Tan HJ; Meyer AM; Kuo TM; Smith AB; Wheeler SB; Carpenter WR; Nielsen ME
Cancer; 2015 Mar; 121(6):836-43. PubMed ID: 25410684
[TBL] [Abstract][Full Text] [Related]
12. Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.
Roth ME; O'Mara AM; Seibel NL; Dickens DS; Langevin AM; Pollock BH; Freyer DR
J Oncol Pract; 2016 Apr; 12(4):e388-95. PubMed ID: 27026648
[TBL] [Abstract][Full Text] [Related]
13. Reforming the community research program: from Community Clinical Oncology Program to the National Cancer Institute Community Oncology Research Program.
Zon RT
Am Soc Clin Oncol Educ Book; 2014; ():e116-9. PubMed ID: 24857089
[TBL] [Abstract][Full Text] [Related]
14. Performance in quasi-firms: an example from the Community Clinical Oncology Program.
Lacey LM; Hynes DM; Kaluzny AD
J Health Hum Resour Adm; 1992; 14(3):307-26. PubMed ID: 10118501
[TBL] [Abstract][Full Text] [Related]
15. Provider-based research networks demonstrate greater hospice use for minority patients with lung cancer.
Penn DC; Stitzenberg KB; Cobran EK; Godley PA
J Oncol Pract; 2014 Jul; 10(4):e182-90. PubMed ID: 24781367
[TBL] [Abstract][Full Text] [Related]
16. Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.
Kaluzny AD; Lacey LM; Warnecke R; Hynes DM; Morrissey J; Ford L; Sondik E
Health Serv Res; 1993 Jun; 28(2):159-82. PubMed ID: 8514498
[TBL] [Abstract][Full Text] [Related]
17. Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program.
Kaluzny AD; Ricketts T; Warnecke R; Ford L; Morrissey J; Gillings D; Sondik EJ; Ozer H; Goldman J
J Natl Cancer Inst; 1989 Nov; 81(22):1717-25. PubMed ID: 2681795
[TBL] [Abstract][Full Text] [Related]
18. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.
Roth ME; Unger JM; O'Mara AM; Lewis MA; Budd T; Johnson RH; Pollock BH; Blanke C; Freyer DR
Cancer Med; 2020 Mar; 9(6):2146-2152. PubMed ID: 32009305
[TBL] [Abstract][Full Text] [Related]
19. Evaluating productivity in clinical research programs: the National Cancer Institute's (NCI) Community Clinical Oncology Program (CCOP).
Hynes DM; McLaughlin CP; Kaluzny AD; Ford LP; Sondik E
J Med Syst; 1992 Dec; 16(6):247-67. PubMed ID: 1304594
[TBL] [Abstract][Full Text] [Related]
20. Translating research into practice: the role of provider-based research networks in the diffusion of an evidence-based colon cancer treatment innovation.
Carpenter WR; Meyer AM; Wu Y; Qaqish B; Sanoff HK; Goldberg RM; Weiner BJ
Med Care; 2012 Aug; 50(8):737-48. PubMed ID: 22437624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
